← Eichor
Study identifier: NCT07132827 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Efficacy and Safety of SHR-1905 Injection in Subjects With Chronic Rhinosinusitis With Nasal Polyps

Condition: Chronic Rhinosinusitis With Nasal Polyps  ·  Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd

PhasePhase 3
Planned participants280
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

The study is being conducted to evaluate the efficacy, and safety of SHR-1905 injection in subjects with chronic rhinosinusitis with nasal polyps (CRSwNP)

This description comes directly from the study's public registry record.

Talk to the study team

HuanHuan Huang  ·  +0518-81220121  ·  huanhuan.huang.hh30@hengrui.com

Always discuss trial participation with your own doctor first.

Locations (1)

Eye & Ent Hospital of Fudan UniversityShanghai, Shanghai Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07132827